FOXO TECHNOLOGIES INC. Payments of Financing Costs
FOXO TECHNOLOGIES INC. (FOXO) reported Payments of Financing Costs of $299.43 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2025-04-15
- FOXO TECHNOLOGIES INC. payments of financing costs for the quarter ending 2023-12-31 was $433.00, a 56.70% decline year-over-year.
- FOXO TECHNOLOGIES INC. payments of financing costs for the quarter ending 2022-12-31 was $1.00K.
- FOXO TECHNOLOGIES INC. payments of financing costs for the quarter ending 2022-09-30 was $520.00K.
- FOXO TECHNOLOGIES INC. payments of financing costs for the quarter ending 2022-06-30 was $0.00.
- FOXO TECHNOLOGIES INC. payments of financing costs for fiscal 2023 was $299.43K, a 44.55% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. payments of financing costs for fiscal 2022 was $540.00K, a 404.67% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. payments of financing costs for fiscal 2021 was $107.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 8 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month | Payments of Financing Costs 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-12-31 | $433.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $299.43K 10-K · filed 2025-04-15 | $299.00K 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $299.00K 10-Q · filed 2024-11-19 | |||||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $521.00K derived: sum of 2 quarters · filed 2024-06-06 | $521.00K derived: sum of 3 quarters · filed 2024-06-06 | $540.00K 10-K · filed 2024-06-06 | ||
| 2022-09-30 | $520.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | $520.00K derived: sum of 2 quarters · filed 2024-06-04 | $539.00K 10-Q/A · filed 2024-06-04 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $19.00K 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | $19.00K 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | $107.00K 10-K · filed 2023-03-31 | |||||
| 2020-12-31 | $259.90K 10-K/A · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |